Johnson & Johnson Common Stock (NYSE:JNJ):
Johnson & Johnson Mourns the Loss of Susan Lindquist, Biomedical Research Pioneer and Member of the Johnson & Johnson Board of Directors.
The company is trading down from yesterday’s close of $115.7.
Johnson & Johnson Common Stock announced a dividend that will be paid on Tuesday December 6th, 2016. The dividend payment will be $0.800 per share for the quarter or $3.20 on an annualized basis. The dividend yield will be $2.81. The ex-dividend date has been established as Friday the 19th of August 2016.
The stock last traded at $115.33 just a bit lower than $117.51, the 50 day moving average and barely below the 200 day moving average of $117.79. The 50 day moving average was down by -1.85% and the 200 day average moved down $-2.46.
The P/E ratio is currently 20.24 and market cap is 315.53B. As of the last earnings report the EPS was $5.70 and is expected to be $6.72 for the current year with 2,735,876,000 shares presently outstanding. Next quarter’s EPS is estimated at $1.76 with next year’s EPS anticipated to be $7.14.
Several ratings analysts have released opinions on the company. On September 13 Jefferies left the stock rating at “Hold” and raised the price target from $109.00 to $115.00. Argus Research both upgraded the stock and lowered the price target on July 20 changing the price objective from $114.00 to $113.00 and altering the rating from “Neutral” to “Hold”.
On July 20 the company was upgraded from “Neutral” to “Hold” with a current price target of $113.00 by Argus Research. June 14 investment analysts at Jefferies left the company rating at “Hold” but moved up the price target to $109.00 from $99.00.
On May 20 analysts at Standpoint Research initiated coverage on the stock with a rating of “Sell”. On May 1 Credit Suisse held the stock rating at “Neutral” and raised the price expectation to $112.00 from $100.00.